Mendelics
Mendelics is the first and largest Brazilian laboratory specializing in genetic diagnostic tests for rare diseases and cancer using Next Generation Sequencing (NGS). It is a pioneer and leader in NGS in Latin America, with the largest processing capacity in the region, analyzing over 10,000 exomes per month. Mendelics offers a range of genetic tests across multiple medical specialties, including oncology, cardiology, neurology, and more. The company differentiates itself with its proprietary AI-powered analysis platform Abracadabra®, which enhances the precision and efficiency of genetic data interpretation. Mendelics holds multiple international accreditations (CAP, PALC, INMETRO, CLIA, ISO/IEC 27001) ensuring high-quality and reliable results. It serves patients through health insurance plans and direct requests, aiming to make genomic analysis accessible and fast.
Mendelics
Mendelics is the first and largest Brazilian laboratory specializing in genetic diagnostic tests for rare diseases and cancer using Next Generation Sequencing (NGS). It is a pioneer and leader in NGS in Latin America, with the largest processing capacity in the region, analyzing over 10,000 exomes per month. Mendelics offers a range of genetic tests across multiple medical specialties, including oncology, cardiology, neurology, and more. The company differentiates itself with its proprietary AI-powered analysis platform Abracadabra®, which enhances the precision and efficiency of genetic data interpretation. Mendelics holds multiple international accreditations (CAP, PALC, INMETRO, CLIA, ISO/IEC 27001) ensuring high-quality and reliable results. It serves patients through health insurance plans and direct requests, aiming to make genomic analysis accessible and fast.